The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
816
April 20, 1990
View Complete Issue         Table of Contents 2019 
Desmopressin for Nocturnal Enuresis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Desmopressin for Nocturnal Enuresis
April 20, 1990 (Issue: 816)
Desmopressin acetate (DDAVP -Rorer), a synthetic analog of the natural human antidiuretic hormone arginine vasopressin, was recently approved by the US Food and Drug Administration for treatment of primary nocturnal enuresis. DDAVP Nasal Spray, ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Desmopressin for Nocturnal Enuresis
Article code: 816b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.